Local Institution - 2106 — Ann Arbor, Michigan

Local Institution - 2106 is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 2106 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumors, MET Gene Alterations.

Sponsors: Turning Point Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 2106?

Local Institution - 2106 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 2106 conducted?

Local Institution - 2106 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumors, MET Gene Alterations.

Is Local Institution - 2106 accredited by Crixeo Health?

Local Institution - 2106 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 2106?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.